REAL Physician Influence. Time to bring your KOL programming into the digital age! Tweets by @chimoose

Austin, TX
Looking to find the perfect combination of strengths in KOLs and online influencers? Our latest blog post uncovers the secrets of multi-layered, segmented influencer lists. Stay tuned for expert insights! #KOL #MedAffairs #PharmaMarketing #MedTech buff.ly/3PhDGlB
1
5
386
HealthQuant retweeted
🚀 Opening #IUCS26 | From a meeting to a global GU oncology community The opening session highlighted the vision behind IUCS and the creation of IUCS CIC, a non-profit Community Interest Company dedicated to advancing multidisciplinary care, translational research and clinical education across genitourinary cancers. ⚪ Building an international and multidisciplinary GU oncology community ⚪ Accelerating evidence-based innovation ⚪ Connecting translational research with everyday clinical practice ⚪ Strengthening education, collaboration and investigator-led research ⚪ Bringing together expertise across countries and healthcare systems ⚪ Keeping the ultimate goal clear: better outcomes for our patients Great to see the community gathered in Guildford and ready for two days of science, discussion and collaboration. With leadership and contributions from @gbanna74 @ravikanesvaran @PasRescigno @alison_tree @amg120395 @ManiamAkash @neerajaiims @montypal @PGrivasMDPhD @ParamMariappan @DrYukselUrun @dmukherji @nataliagandur @MicheleMaffezz @yekeduz_emre and the wider #IUCS26 faculty. @myESMO @ASCO @ASCOPost @AmerUrological @urotoday @UrologyTimes @OncLive @ecancer @Uroweb #GUOncology #UroOnc #ClinicalResearch #MedicalEducation #GlobalOncology
1
12
32
2,209
Do you remember when you joined X? I do! #MyXAnniversary
14
HealthQuant retweeted
If you’re in Stockholm for #EHA2026, check out Dr. Stephen Schuster’s presentation of our vispa-cel data to hear about long-term durability after a single dose of vispa-cel in patients with relapsed or refractory B cell non-Hodgkin lymphoma. #CellTherapy #CRISPR $CRBU
2
11
593
HealthQuant retweeted
really great to see @tamarindbio land a unique deal that i think may be a bellwether for more software in pharma
We’re proud to share that @TamarindBio has been selected to build, host, and operate the inference infrastructure layer for TuneLab2.0, the next evolution of the platform. @EliLillyandCo TuneLab is a first-of-its-kind, collaborative AI/ML drug discovery platform, bringing models trained on over $1B worth of Lilly proprietary data to the biotech ecosystem. Tamarind will power TuneLab’s scalable drug discovery workflows and model inference.
1
43
6,452
This could come in handy!
If you ever get lost in the Milky Way galaxy, this is your map to get back to EARTH.
41
HealthQuant retweeted
Ahead of the @ASCO-2025, @Larvol CLIN spotlights the top companies driving the future of cancer research. Get the latest #ASCO25 updates as they happen: t.ly/7TCD6 #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights | @ADesaiMD | @HHorinouchi | @DrRiyazShah | @FordePatrick | @lungoncdoc | @matteolambe | @ErikaHamilton9 | @PTarantinoMD | @DrChoueiri | @AndreaNecchi | @GillSharlene | @mtmdphd | @SuyogCancer
11
24
10,788
Replying to @tapshah21
@tapshah21 Hi Tapan! Yesterday my app stopped returning user data when calling the X ID user endpoint. Nothing in the documentation implies that was intentionally deprecated; can you please help?
2
47
PS I’ve had a Basic plan for a couple of years and have had no problems thus far …
26
Interesting #MedTwitter stats: Comparing monthly twitter posts from global doctors, Posts from January-June of 2023 and 2024, physician posts were slightly down (February was actually up 2%). 1/2
1
1
285
2/2 But July, August and September of 2024 were each significantly higher than the same months in 2023. I'm encouraged that doctors are coming back. We'll keep watching! #MedTwitter #HCSM #HCSMEU
24
Man, that is a tough analysis - but it's hard to argue. We have to find different ways ...
The Bluebird layoffs this week "offered another reminder that groundbreaking genetic medicines capable of transforming the lives of people with inherited disease are not now — and may never become — a sustainable business." via @adamfeuerstein statnews.com/2024/09/26/gene…
28
Thanks to @JNJInnovMed for their Transparency Report - and to @brianreid's Cost Curve newsletter for pointing us to it!
Kudos to @JNJInnovMed for their excellent & comprehensive Transparency Report, which Cost Curve (@brianreid) calls the best in the industry. transparencyreport.janssen.c… #Pharma #HealthInnovation #DrugPricing
1
1
41